about
Specific strains of Escherichia coli are pathogenic for the endometrium of cattle and cause pelvic inflammatory disease in cattle and miceToll-like receptor 4 mediates the response of epithelial and stromal cells to lipopolysaccharide in the endometrium.Mycoplasma genitalium: a review.Characterisation of the bacterial microbiota of the vagina of dairy cows and isolation of pediocin-producing Pediococcus acidilacticiLipopolysaccharide- and Lipoteichoic Acid-mediated Pro-inflammatory Cytokine Production and Modulation of TLR2, TLR4 and MyD88 Expression in Human Endometrial CellsLimitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease researchLipopolysaccharide initiates inflammation in bovine granulosa cells via the TLR4 pathway and perturbs oocyte meiotic progression in vitroThe effect of Escherichia coli lipopolysaccharide and tumour necrosis factor alpha on ovarian functionBacterial lipopolysaccharide induces an endocrine switch from prostaglandin F2alpha to prostaglandin E2 in bovine endometriumEstablishment of hydrochloric acid/lipopolysaccharide-induced pelvic inflammatory disease model.Defining postpartum uterine disease and the mechanisms of infection and immunity in the female reproductive tract in cattlePHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Uterine infection: linking infection and innate immunity with infertility in the high-producing dairy cow.Effect of lipopolysaccharide on circadian clock genes Per2 and Bmal1 in mouse ovary.Lipopolysaccharide reduces the primordial follicle pool in the bovine ovarian cortex ex vivo and in the murine ovary in vivo.Conjugated linoleic acids attenuate LPS-induced pro-inflammatory gene expression by inhibiting the NF-κB translocation through PPARγ in buffalo granulosa cells.
P2860
Q27334535-FA0687D0-D224-4BD6-9624-5400AA8D9C34Q33705139-13F6ABB7-18CF-46E7-82DF-646F4576EE9DQ34403627-B85EEC82-B643-469C-B415-62C0B8FB9580Q34565574-F38B7CBD-712A-4E0C-8675-A41EC9A0A297Q35276462-3A0E97C0-D51E-47E5-A76D-9A99B37BB1E8Q35549536-AF1745D9-64EF-4A3C-8D9E-F6C6FFB936BBQ36193447-B135DE1C-A7A9-4A1D-BA6B-75B9E845D10EQ37241891-E1673F68-3165-4BA6-ADD7-B6D86A8CD8DEQ37252064-3F0BA8D1-4DF9-417C-A898-BFC433832E39Q37285108-0A564437-9883-40B1-ACF8-EB7B1DE993C2Q37443400-C3EE8399-41B2-4D39-ABC6-46CB9550FBA7Q38505708-7E00382D-CE97-4339-A0FB-9B09394674C8Q38954395-52BE18A0-FF18-4236-9AF0-EB03BEB4852FQ48628202-4C2FFF57-75F7-4F3E-AB89-474BE59727A4Q53053167-E478AEE2-632C-4B6D-86C7-F7C04E0EC50C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An update on pelvic inflammatory disease
@ast
An update on pelvic inflammatory disease
@en
An update on pelvic inflammatory disease
@nl
type
label
An update on pelvic inflammatory disease
@ast
An update on pelvic inflammatory disease
@en
An update on pelvic inflammatory disease
@nl
prefLabel
An update on pelvic inflammatory disease
@ast
An update on pelvic inflammatory disease
@en
An update on pelvic inflammatory disease
@nl
P2860
P356
P1476
An update on pelvic inflammatory disease
@en
P2093
P2860
P356
10.1136/STI.78.1.18
P577
2002-02-01T00:00:00Z